National TB prevalence surveys in the COVID-19 era.

Tadolini, M; Onozaki, I

Tadolini, M; Onozaki, I.

Tadolini M; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant´Orsola, Bologna, Italy, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Onozaki I; Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.

Int J Tuberc Lung Dis ; 26(1): 4-5, 2022 01 01.

Article in English | MEDLINE | ID: covidwho-1598516

Subject(s)

COVID-19; Tuberculosis, Pulmonary; Tuberculosis; Humans; Prevalence; SARS-CoV-2; Tuberculosis/diagnosis; Tuberculosis/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Tuberculosis, Pulmonary / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Int J Tuberc Lung Dis Year: 2022 Document Type: Article Affiliation country: Ijtld.21.0585

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google